Pudexacianinium Chloride
Sentinel Lymph Node Biopsy
Astellas Pharma IncSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Sentinel Lymph Node Biopsy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TECHNETIUM TC 99M SULFUR COLLOID Novadaq Technologies ULC, now a part of Stryker | Phase 4 | BB |
IC2000 Novadaq Technologies ULC, now a part of Stryker | Phase 3 | BB |
Tilmanocept Memorial Health University Medical Center | Phase 4 | B |
MIDAZOLAM Jun Zhang | N/A | D |
PROPOFOL Jun Zhang | N/A | D |
View all 9 →
Same molecule, other indications
Pudexacianinium Chloride is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →